Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril versus amlodipine for postpartum blood pressure control
IRCT20260522069482N1Phase 3Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of enalapril, amlodipine and labetalol in hypertension (HTN) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Mean reduction in systolic blood pressure, Mean reduction in diastolic blood pressure and 3 more. Started Oct 2026; status: recruiting.
02
Drugs
enalaprilamlodipinelabetalol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20260522069482N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260522069482N1.